๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Quinazolines as novel anti-inflammatory histone deacetylase inhibitors

โœ Scribed by Zhigang Lin; Pamela M. Murray; Yaoyao Ding; William A. Denny; Lynnette R. Ferguson

Book ID
113809461
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
500 KB
Volume
690
Category
Article
ISSN
0027-5107

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Novel Sulfonamide Derivatives as Inhibit
Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase
โœ Paulโ€…W. Finn; Morwena Bandara; Chris Butcher; Angela Finn; Ruth Hollinshead; Nag ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ German โš– 374 KB

## Abstract Inhibition of the enzyme histone deacetylase (HDAC) is emerging as a novel approach to the treatment of cancer. A series of novel sulfonamide derivatives were synthesized and evaluated for their ability to inhibit human HDAC. Compounds were identified which are potent enzyme inhibitors,

Dietary agents as histone deacetylase in
Dietary agents as histone deacetylase inhibitors
โœ Melinda C. Myzak; Emily Ho; Roderick H. Dashwood ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

## Abstract In cancer cells, an imbalance often exists between histone acetyltransferase (HAT) and histone deacetylase (HDAC) activities, and various drug companies are actively seeking competitive HDAC inhibitors for chemotherapeutic intervention. Cancer cells appear to be more sensitive than nont